Skip to main content

Table 1 Patient characteristics and findings

From: Effect of cellular and extracellular pathology assessed by T1 mapping on regional contractile function in hypertrophic cardiomyopathy

N 50 FH of HCM, n (%) 19 (38)
Male gender, n (%) 37 (74) CMR findings  
Age, years 46.9 ± 11.7 LV EDV, ml/m2 78.7 ± 13.1
Height, cm 171.2 ± 9.0 LV EF, % 62.3 ± 5.9
Weight, kg 81.7 ± 14.6 LV Mass, g/m2 72.8 ± 26.3
Body mass index, kg/m2 27.7 ± 3.7 LAV, ml/m2 59.3 ± 13.5
Systolic blood pressure, mmHg 125.5 ± 17.6 LGE, n (%) 35 (70)
Diastolic blood pressure, mmHg 74.5 ± 12.5 Medications  
Heart rate 60.6 ± 10.2 Beta blocker, n (%) 24 (48)
Echocardiography   CC blocker, n (%) 8 (16)
Maximum wall thicknessa (mm) 19.3 ± 4.9 Disopyramide, n (%) 4 (8)
LVOT obstruction, n (%) 11 (22) Diuretic, n (%) 2 (4)
Resting LVOT gradient, mmHg 68.5 ± 40.0   
  1. CC calcium channel, EDV end diastolic volume indexed to body surface area, EF ejection fraction, FH family history, LAV left atrial volume indexed to body surface area, LGE late gadolinium enhancement, LV left ventricle, LVOT left ventricular outflow tract
  2. aIn 5 subjects with apical or localized lateral hypertrophy maximum wall thickness is taken from CMR